Actively Recruiting
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
Led by University of Zurich · Updated on 2024-05-16
200
Participants Needed
3
Research Sites
252 weeks
Total Duration
On this page
Sponsors
U
University of Zurich
Lead Sponsor
M
M.D. Anderson Cancer Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.
CONDITIONS
Official Title
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients (18 years or more), female or male
- Histologically confirmed diagnosis of extra-CNS primary solid cancer
- Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria
- Performance status compatible with enrolment into clinical trials
- Ability to consent
- Signed informed consent form from patient
- Participation in a parallel clinical trial is allowed in this non-interventional study
You will not qualify if you...
- Inability to give informed consent
- Inability to adhere to recommended follow-up according to the treating physician
- Vulnerable participants will not be included
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
2
Netherlands Cancer Institute
Amsterdam, Netherlands
Actively Recruiting
3
University Hospital Zurich
Zurich, Switzerland
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here